Two male patients from an extended seven generation Turkish family diagnosed with Renpenning syndrome: identifying the causative mutation and review of the literature

Yıl 2022, Cilt: 8 Sayı: 3, 420 - 427, 04.05.2022

Bayram Toraman , Tuba Dinçer , Gülden Budak , Cilem Bilginer , Hülya Kayserili , Ersan Kalay

https://doi.org/10.18621/eurj.924346

Öz

Intellectual disability (ID) is a lifelong condition that begins during the developmental period, and characterized by significant limitations in intellectual functioning and adaptive behavior including social, conceptual and practical skills. In these case series, we aimed to identify the genetic etiopathogenesis of two male patients with ID from a seven-generation large-Turkish family. Two affected boys with syndromic ID were evaluated. Genome-wide auto zygosity mapping was performed on affected individuals and other available healthy family members for identifying shared chromosomal segments between affected individuals. Critical region co-segregating with the disease was confirmed and narrowed down by short tandem repeat polymorphism markers. Whole exome sequencing was performed to identify the responsible genes and mutations. Sanger sequencing was performed for segregation analysis. We performed a comprehensive genetic analysis to reveal the underlying genetic aetiology of the patients and identified a mutation on PQBP1 gene (NM_005710.2:c.459-462delAGAG) that is associated with Renpenning syndrome. Considering the clinical findings and genetic data of the affected probands, the patients were diagnosed with Renpenning syndrome and this is the first report for Renpenning syndrome with attention deficit and hyperactivity disorder comorbidity.

Anahtar Kelimeler

Renpenning syndrome, PQBP1, intellectual disability, microcephaly

Teşekkür

We thank the families of the patients involved in this study for participating in the study. In addition, we thank Prof. Dr. A. Nurten AKARSU from Hacettepe University Faculty of Medicine, Department of Medical Genetics for her performing of the snp-array autozygosity mapping and evaluating the manuscript scientifically.

Kaynakça

• 1. Stevenon RE, Procopio-Allen AM, Schroer RJ, Collins JS. Genetic syndromes among individuals with mental retardation. Am J Med Genet A 2003;123A:29-32.
• 2. Chiurazzi P, Pirozzi F. Advances in understanding – genetic basis of intellectual disability. F1000Research 2016;5:599.
• 3. Ropers H-H. X-linked mental retardation: many genes for a complex disorder. Curr Opin Genet Dev 2006;16:260-9.
• 4. Stevenson RE, Bennett CW, Abidi F, Kleefstra T, Porteous M, Simensen RJ, et al. Renpenning syndrome comes into focus. Am J Med Genet A 2005;134:415-21.
• 5. Germanaud D, Rossi M, Bussy G, et al. The Renpenning syndrome spectrum: new clinical insights supported by 13 new PQBP1-mutated males. Clin Genet 2011;79:225–235.
• 6. Mameesh MM, Al-Kindy A, Al-Yahyai M, Ganesh A. Microphthalmos-anophthalmos-coloboma (MAC) spectrum in two brothers with Renpenning syndrome due to a truncating mutation in the polyglutamine tract binding protein 1 (PQBP1) gene. Ophthalmic Genet 2019;40:534-40.
• 7. Cho RY, Peñaherrera MS, Du Souich C, Huang L, Mwenifumbo J, Nelson TN, et al. Renpenning syndrome in a female. Am J Med Genet Part A 2020;182:498-503.
• 8. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, et al. Primer3-new capabilities and interfaces. Nucleic Acids Res 2012;40:e115.
• 9. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-303.
• 10. Silva RR, Alpert M, Pouget E, Silva V, Trosper S, Reyes K, et al. A rating scale for disruptive behavior disorders, Based on the DSM-IV Item Pool. Psychiatr Q 2005;76:327-39.
• 11. Renpenning H, Gerrard JW, Zaleski WA, Tabata T. Familial sex-linked mental retardation. Can Med Assoc J 1962;87:954-6.
• 12. Rappaport N, Nativ N, Stelzer G, et al. MalaCards: an integrated compendium for diseases and their annotation. Database 2013;2013:bat018.
• 13. Ropers H-H, Hamel BCJ. X-linked mental retardation. Nat Rev Genet 2005;6:46-57.
• 14. des Portes V. X-linked mental deficiency. In: Handbook of clinical neurology. 2013:pp. 297-306.
• 15. Musante L, Kunde S-A, Sulistio TO, Fischer U, Grimme A, Frints SGM, et al. Common pathological mutations in PQBP1 induce nonsense-mediated mRNA decay and enhance exclusion of the mutant exon. Hum Mutat 2010;31:90-8.
• 16. Zhang X-Y, Qi J, Shen Y-Q, Liu X, Liu A, Zhou Z, et al. Mutations of PQBP1 in Renpenning syndrome promote ubiquitin-mediated degradation of FMRP and cause synaptic dysfunction. Hum Mol Genet 2017;26:955-68.
• 17. Waragai M, Lammers CH, Takeuchi S, Imafuku I, Udagawa Y, Kanazawa I, et al. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum Mol Genet 1999;8:977-87.
• 18. Wang Q, Moore MJ, Adelmant G, Marto JA, Silver PA. PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth. Genes Dev 2013;27:615-26.
• 19. Kurt Colak F, Eyerci N, Aytekin C, Eksioğlu AS. Renpenning syndrome in a Turkish patient: de novo variant c.607C>T in PACS1 and hypogammaglobulinemia phenotype. Mol Syndromol 2020;11:157-61.
• 20. Schuurs-Hoeijmakers JHM, Landsverk ML, Foulds N, Kukolich MK, Gavrilova RH, Greville-Heygate S, et al. Clinical delineation of the PACS1-related syndrome--Report on 19 patients. Am J Med Genet A 2016;170:670-5.
• 21. Stern D, Cho MT, Chikarmane R, Willaert RW, Retterer K, Kendal F, et al. Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizures. Clin Genet 2017;92:221-3.
• 22. Hoshino Y, Enokizono T, Imagawa K, Tanaka R, Suzuki H, Fukushima H, et al. Schuurs-Hoeijmakers syndrome in two patients from Japan. Am J Med Genet A 2019;179:341-3.
• 23. Schuurs-Hoeijmakers JHM, Oh EC, Vissers LELM, Swinkwls MEM, Gilissen C, Willemsen MA, et al. Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome. Am J Hum Genet 2012;91:1122-7.
• 24. M Golabi, M Ito BH. A new X-linked multiple congenital anomalies/ mental retardation syndrome. Am J Med Genet 1984;17:367-74.
• 25. Sutherland GR, Gedeon AK, Haan EA, Woodroffe P, Mulley JC, et al. Linkage studies with the gene for an X-linked syndrome of mental retardation, microcephaly and spastic diplegia (MRX2). Am J Med Genet 1988;30:493-508.
• 26. Hamel BCJ, Mariman ECM, van Beersum SEC, Schoonbrood-Lenssen AM, Ropers HH. Mental retardation, congenital heart defect, cleft palate, short stature, and facial anomalies: a new X-linked multiple congenital anomalies/mental retardation syndrome: clinical description and molecular studies. Am J Med Genet 1994;51:591-7.
• 27. Lenski C, Abidi F, Meindl A, Gibson A, Platzer M, Kooy RF, et al. Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. Am J Hum Genet 2004;74:777-80.